Geisinger has begun an artificial intelligence pilot program to help identify patients at high risk for breast cancer, health ...
A new study suggests that artificial intelligence (AI) could open up new avenues for sepsis research, researchers reported ...
A new study suggests that artificial intelligence (AI) could open up new avenues for sepsis research, researchers reported ...
Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated ...
Ethics, Shadow, and Catharsis in Practice. Psychology, 16, 1182-1192. doi: 10.4236/psych.2025.1610069 . The intersection of ...
On May 19, Sujata Ghadke was wheeled into an operation theatre in Pune, western Maharashtra. A non-cancerous tumour near her ...
The U.S. Food and Drug Administration (FDA) has issued a Class II risk level for certain Neutrogena makeup remover wipes. The ...
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
Introduction Antimicrobial resistance (AMR) poses a global health threat, especially in low-income and middle-income countries. Community health workers (CHWs) are key actors in infection management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback